Spinal Cord Stimulation (SCS) Commercialization

This is the breadcrumbs block. Breadcrumb will populate on actual page.

Regulatory Considerations

A listing of regulatory resources for SCS:

Medical device fact sheet

Medical Device Active Licence Listing (MDALL)

e-Learning tool: Understanding How Medical Devices are Regulated in Canada – Premarket Regulation:

    • This tool is recommended for various medical device stakeholders, including manufacturers, importers, distributors, consultants, healthcare groups and academia.

Application forms

    • Separate application forms for each class of device as well as for investigational testing authorization (ITA).

Medical devices in Canada

Praxis SCI Incubate & Accelerate

The Praxis Commercialization team runs SCI Incubate & Accelerate programs. These programs provide targeted consumer and research validation and mentorship, as well as access to our commercialization network.

PathMaker Neurosystems

A member of the 2020 Praxis SCI Accelerate cohort, PathMaker Neurosystems is a clinical-stage neuromodulation company developing breakthrough non-invasive systems for the treatment of patients with serious neurological disorders, including SCI.

Visit their website.

You May Also Be Interested In…

You May Also Be Interested In…


Spinal Cord Stimulation Platforms for Collaboration in SCI Research and Care


Spinal Cord Stimulation Consumer Priorities